Obi O, Obiezue R, Eze D, Adebote D
J Parasit Dis. 2025; 49(1):13-28.
PMID: 39975623
PMC: 11833005.
DOI: 10.1007/s12639-024-01740-9.
Zhang Y, Liu X, Shen T, Wang Q, Zhou S, Yang S
Nat Biomed Eng. 2025; 9(2):249-267.
PMID: 39920212
DOI: 10.1038/s41551-025-01344-5.
Deng Y, Sheng Y, Zhang G, Sun Y, Wang L, Ji P
J Virol. 2024; 98(2):e0165023.
PMID: 38271227
PMC: 10878242.
DOI: 10.1128/jvi.01650-23.
Ma F, Xu Q, Wang A, Yang D, Li Q, Guo J
Proc Natl Acad Sci U S A. 2024; 121(4):e2305745121.
PMID: 38236731
PMC: 10823241.
DOI: 10.1073/pnas.2305745121.
Jin Y, Fayyaz A, Liaqat A, Khan A, Alshammari A, Wang Y
Comput Biol Med. 2023; 159:106893.
PMID: 37116237
PMC: 10083144.
DOI: 10.1016/j.compbiomed.2023.106893.
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections.
Koger-Pease C, Perera D, Ndao M
Pharmaceuticals (Basel). 2023; 16(3).
PMID: 36986434
PMC: 10058461.
DOI: 10.3390/ph16030334.
mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches.
Althurwi H, Alharthy K, Albaqami F, Altharawi A, Javed M, Muhseen Z
Int J Environ Res Public Health. 2022; 19(20).
PMID: 36293632
PMC: 9602923.
DOI: 10.3390/ijerph192013054.
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after....
Parriott J, Stewart J, Smith D, Curran S, Bauer C, Wyatt T
Pharmaceutics. 2022; 14(9.
PMID: 36145590
PMC: 9502690.
DOI: 10.3390/pharmaceutics14091843.
Frontiers in the Standardization of the Plant Platform for High Scale Production of Vaccines.
Citiulo F, Crosatti C, Cattivelli L, Biselli C
Plants (Basel). 2021; 10(9).
PMID: 34579360
PMC: 8467261.
DOI: 10.3390/plants10091828.
Bridging the B Cell Gap: Novel Technologies to Study Antigen-Specific Human B Cell Responses.
Utset H, Guthmiller J, Wilson P
Vaccines (Basel). 2021; 9(7).
PMID: 34358128
PMC: 8310089.
DOI: 10.3390/vaccines9070711.
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.
Schijns V, Majhen D, Van der Ley P, Thakur A, Summerfield A, Berisio R
Pharmaceutics. 2021; 13(4).
PMID: 33917629
PMC: 8067490.
DOI: 10.3390/pharmaceutics13040501.
Virus-like Particle (VLP) Mediated Antigen Delivery as a Sensitization Tool of Experimental Allergy Mouse Models.
Kim J, Oh J, Kang C, Choi Y
Immune Netw. 2020; 20(4):e35.
PMID: 32895622
PMC: 7458801.
DOI: 10.4110/in.2020.20.e35.
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.
Alshammari A, Smith D, Parriott J, Stewart J, Curran S, McCulloh R
ACS Infect Dis. 2020; 6(5):1169-1181.
PMID: 32233506
PMC: 7279522.
DOI: 10.1021/acsinfecdis.0c00005.
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against....
Tallapaka S, Karuturi B, Yeapuri P, Curran S, Sonawane Y, Phillips J
Int J Pharm. 2019; 565:242-257.
PMID: 31077762
PMC: 6935512.
DOI: 10.1016/j.ijpharm.2019.05.012.
Immune Responses to the Sexual Stages of Parasites.
Kengne-Ouafo J, Sutherland C, Binka F, Awandare G, Urban B, Dinko B
Front Immunol. 2019; 10:136.
PMID: 30804940
PMC: 6378314.
DOI: 10.3389/fimmu.2019.00136.
Rational Design and In Vivo Characterization of Vaccine Adjuvants.
Schmidt S, Pedersen G, Christensen D
ILAR J. 2019; 59(3):309-322.
PMID: 30624655
PMC: 6927902.
DOI: 10.1093/ilar/ily018.
Synthetic biology for bioengineering virus-like particle vaccines.
Charlton Hume H, Vidigal J, Carrondo M, Middelberg A, Roldao A, Lua L
Biotechnol Bioeng. 2019; 116(4):919-935.
PMID: 30597533
PMC: 7161758.
DOI: 10.1002/bit.26890.
Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
Mosaheb M, Wetzler L
Vaccine. 2018; 36(50):7689-7699.
PMID: 30381152
PMC: 6279244.
DOI: 10.1016/j.vaccine.2018.10.074.
Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.
Handel A, Li Y, McKay B, Pawelek K, Zarnitsyna V, Antia R
PLoS Comput Biol. 2018; 14(10):e1006505.
PMID: 30273336
PMC: 6181424.
DOI: 10.1371/journal.pcbi.1006505.
Exploiting vita-PAMPs in vaccines.
Blander J, Barbet G
Curr Opin Pharmacol. 2018; 41:128-136.
PMID: 29890457
PMC: 6110613.
DOI: 10.1016/j.coph.2018.05.012.
